KEAP1 and hepatocellular carcinoma: KRAL activation promotes chemo-sensitization to HCC cells by targeting the miR-141/KEAP1 axis as a competing endogenous RNA (ceRNA), with a consequent upregulation of KEAP1 and a silencing of NFE2L2, respectively [71].